Search the Newsreel

Press Release: MarketWise, Inc. Declares Quarterly Dividend on Class A Common Stock of $0.45 Per Share

MarketWise, Inc. (NASDAQ: MKTW) announced that its Board of Directors has declared a quarterly cash dividend of $0.45 per share of Class A common stock. The dividend is payable on September 15, 2026, to stockholders of record as of the close of business on …

MarketWise, Inc. (MKTW) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of MarketWise, Inc. (MKTW) stock, including its current price, dividend information, historical performance, financial data, and analyst insights. MarketWise operates a multi-brand platform offering financial research, software, education, and tools for self-directed investors. The company's stock …

Twilio Inc. gibt Ergebnisprognose für das dritte Quartal bis zum 30. September 2026 ab

FMR LLC discloses 7.6% Twist Bioscience (TWST) holding in new ownership filing

FMR LLC has filed a Schedule 13G, disclosing a beneficial ownership of 7.6% in Twist Bioscience Corp (TWST) as of June 30, 2026. This translates to 4,703,044.11 shares, with FMR LLC holding sole dispositive power over all these shares and sole voting power over …

Twin Disc (NASDAQ:TWIN) Stock Passes Above 200 Day Moving Average - Here's What Happened

Twin Disc (NASDAQ:TWIN) stock recently surpassed its 200-day moving average, trading as high as $24.56 before closing at $23.81. Analysts maintain a "Moderate Buy" consensus rating with an average target price of $30.00, including a new "Buy" rating from Lake Street Capital. Despite missing …

MarketWise Q2 2026: Billings +57% YoY to $91.2M; Net Loss $2.6M; Raises FY Billings Guide to $330M

MarketWise reported strong Q2 2026 results with billings up 57% year-over-year to $91.2 million and cash from operating activities increasing by 25.7% to $22.4 million. Despite a net loss of $2.6 million, the company raised its full-year 2026 billings guidance to $330 million and …

MarketWise (NASDAQ: MKTW) swings to Q2 loss as Billings jump 57%

MarketWise (NASDAQ: MKTW) reported a Q2 2026 net loss of $2.6 million, a significant swing from a net income of $15.3 million in the prior year, despite a 56.7% jump in Billings to $91.2 million. The company's net revenue declined by 5.2% year-over-year to …

MarketWise (NASDAQ: MKTW) lifts 2026 billings target after 57% Q2 surge

MarketWise (NASDAQ: MKTW) reported a significant 57% year-over-year increase in Q2 2026 Billings to $91.2 million, leading the company to raise its full-year 2026 Billings target by 10% to $330 million. Despite a decline in GAAP Net Revenue and a net loss for the …

MarketWise (MKTW) Earnings Date and Reports 2026

BlackRock, Inc. Buys Twin Disc Inc (TWIN) -- Shares Look 51% Ove

MarketWise declares $0.45 quarterly dividend per share By Investing.com

MarketWise, Inc. (NASDAQ:MKTW) announced a quarterly cash dividend of $0.45 per share of Class A common stock, along with a $0.25 per unit distribution to LLC unit holders. These dividends, previously categorized as "special," will now be regular, stemming from a recurring regular dividend …

Twist Bioscience Nets ~$327 Million From $96-Per-Share Underwritten Stock Offering

Twist Bioscience has successfully completed an underwritten stock offering, selling 3,125,000 shares of common stock at $96.00 per share, with the underwriters fully exercising their option for an additional 468,750 shares. This offering is expected to generate approximately $327.1 million in net proceeds after …

MarketWise Declares Quarterly Cash Dividend of $0.45 per Share for Class A Common Stock and $0.25 per LLC Unit

MarketWise, Inc. has announced a quarterly cash dividend of $0.45 per share for Class A common stockholders and $0.25 per LLC unit, payable on September 30, 2026, with a record date of August 19, 2026. The company has recharacterized a portion of its dividends …

MarketWise changes how $0.20 of its quarterly dividend is labeled

MarketWise (NASDAQ: MKTW) has declared a quarterly cash dividend of $0.45 per share on its Class A common stock, payable September 30, 2026, to holders of record on August 19, 2026. This dividend now fully classifies the $0.20 previously termed "special" (arising from excess …

Twist Bioscience (TWST) Jumps As Guidance, Offering Reset The Trade

Twist Bioscience (TWST) saw its stock jump over 16% after reporting strong Q3 revenue, exceeding consensus, and raising its Q4 and FY26 revenue guidance. The company also announced an upsized $300M stock offering to fund R&D and manufacturing expansion, which, despite dilution, is seen …

Twist Bioscience (NASDAQ: TWST) COO sells 2,888 shares for tax withholding

Patrick John Finn, President and COO of Twist Bioscience (NASDAQ: TWST), sold 2,888 shares of common stock on August 3, 2026, at an average price of $85.3212 per share. This transaction was a mandatory "sell to cover" to satisfy tax withholding obligations related to …

Twist Bioscience TWST Rallies As Guidance And Capital Raise Reset The Bar

Twist Bioscience (TWST) experienced a significant stock rally of 16.14% following positive Q3 results, robust Q4 and FY26 guidance, and a $300M equity offering. The company beat revenue expectations, increased its full-year guidance, and is targeting adjusted EBITDA breakeven, signaling an improved path towards …

Twist Biosciences: Accelerating Growth, Diminishing Margin Of Safety (NASDAQ:TWST)

Titan International Q2 sales rise as consumer segment drives growth

Titan International reported increased sales, profitability, and cash generation during the second quarter of 2026, primarily fueled by significant growth in its consumer segment. The company also saw improved demand for its Specialty products. The full article content is behind a paywall, requiring a …

Twist Announces Pricing Of $300 Mln Underwritten Upsized Public Offering

(RTTNews) - Twist Bioscience Corporation (TWST), a mid-cap growth biotechnology company, announced the pricing of an underwritten public offering of $250 million worth of shares of its common stock. The company priced 3.12 million shares at $96.00 per share. Twist also granted underwriters a …

Twist Bioscience (TWST) Jumps As Revenue, Targets And Offering Reshape The Trade

Twist Bioscience (TWST) Stock Rally Faces Pressure From Fresh Losses

Twilio (TWLO) Q2 Earnings: What To Expect

Twist Bioscience prices $300M stock offering at $96 per share

Twist Bioscience Corporation announced it has priced an underwritten public offering of 3,125,000 shares of common stock at $96.00 per share, aiming to raise $300.0 million in gross proceeds. The company has also granted underwriters a 30-day option to purchase additional shares. The net …

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Twist Bioscience Corporation announced the pricing of an upsized underwritten public offering of 3,125,000 shares of its common stock at $96.00 per share, aiming to raise $300.0 million. The company plans to use the net proceeds for research and development investments, expanding manufacturing capacity …

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - August 4, 2026

Twist Bioscience Corporation announced that it will grant a total of 44,434 restricted stock units (RSUs) to 24 recently hired individuals as an inducement for their employment. These grants are made under Twist's Amended and Restated Inducement Equity Incentive Plan, in accordance with Nasdaq …

Twin Disc Inc (TWIN) grants director 179 restricted shares in lieu of cash

Twin Disc Inc. (TWIN) director David W. Johnson was granted 179 restricted shares of common stock on August 3, 2026, in lieu of his quarterly cash retainer. The shares, valued at $22.74 each, will vest on the first anniversary of the issuance date. Following …

Twin Disc (TWIN) grants 357 restricted shares to director Doar

Twin Disc director Michael Doar received a grant of 357 restricted shares of common stock on August 3, 2026, valued at $22.74 per share. These shares were issued in lieu of his quarterly cash retainer under the company’s Amended and Restated 2021 Omnibus Incentive …

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

Twist Bioscience Corporation announced a proposed underwritten public offering of $250.0 million of its common stock, with an option for underwriters to purchase an additional $37.5 million. The company plans to use the net proceeds, along with existing cash, for research and development investments, …

Twist Bioscience Corp stock hits 52-week high at 106.58 USD

Twist Bioscience Corp (TWST) reached a 52-week high of $106.58, with its stock currently trading at $103.80. The company has shown a robust 267.22% increase over the past year and recently reported fiscal third-quarter 2026 revenue of $118.4 million, exceeding expectations. Despite the strong …

Somos Appoints Twilio Telecom Trust Leader Melissa Blassingame to Advisory Board

EAST BRUNSWICK, N.J., Aug. 4, 2026 /PRNewswire/ -- Somos, Inc., a leading global provider of telephone number and identity information services, today announced the appointment of Melissa Blassingame, telecommunications trust and policy leader at Twilio, to its Advisory Board. Her appointment underscores Somos' continued …

Sidoti Reduces Earnings Estimates for Titan International

Sidoti has decreased its Q3 2026 earnings estimates for Titan International (NYSE:TWI) to a loss of $0.06 per share, down from a projected loss of $0.03. The firm anticipates a full-year 2026 loss of $0.19 per share, but expects the company to return to …

Twist Bioscience's 24 New Hires Set to Receive Stock Awards

Twist Bioscience (NASDAQ: TWST) announced it will grant a total of 44,434 restricted stock units (RSUs) to 24 new employees as an inducement to employment. These grants are made under the company's Amended and Restated Inducement Equity Incentive Plan, in compliance with Nasdaq Listing …

Twist Bioscience Corporation Stock 12‑Month Price Target Raised to $109.67, Implies 20% Upside

Analysts have raised the 12-month average price target for Twist Bioscience Corporation (TWST) stock to $109.67, up from $104. This new target suggests a potential 20% upside from its July 31st closing price, with individual forecasts ranging from $85 to $120 per share. The …

Twist Bioscience Corp (TWST) (Q3 2026) Earnings Call Highlights: Record Revenue and AI-Driven ...

Twist Bioscience Corp (TWST) announced record revenue of $118.4 million in Q3 2026, marking its 14th consecutive quarter of growth, with AI-enabled drug discovery orders expected to achieve triple-digit growth. The company improved its gross margin to 52.8% and expects to reach adjusted EBITDA …

Twist Bioscience Corp 2026: Revenue $118.38M, EPS ($0.56) — 10-Q Summary

Twist Bioscience Corp reported its 2026 quarterly results, showing a 23.2% increase in revenue to $118.38M compared to the prior year, driven by growth in DNA synthesis, protein products, and NGS applications. Despite increased revenue, the company's net loss widened to ($35.05M) with a …